Free Trial

Investment Management Corp of Ontario Has $2.63 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Investment Management Corp of Ontario lifted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 48.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,924 shares of the financial services provider's stock after purchasing an additional 3,900 shares during the quarter. Investment Management Corp of Ontario's holdings in CME Group were worth $2,631,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. CWM LLC raised its stake in CME Group by 4.5% during the second quarter. CWM LLC now owns 22,594 shares of the financial services provider's stock worth $4,442,000 after acquiring an additional 976 shares in the last quarter. Simplicity Wealth LLC raised its stake in CME Group by 16.0% during the second quarter. Simplicity Wealth LLC now owns 15,099 shares of the financial services provider's stock worth $2,969,000 after acquiring an additional 2,084 shares in the last quarter. CX Institutional raised its stake in CME Group by 7.7% during the second quarter. CX Institutional now owns 15,639 shares of the financial services provider's stock worth $3,075,000 after acquiring an additional 1,119 shares in the last quarter. Canandaigua National Bank & Trust Co. raised its stake in CME Group by 5.9% during the second quarter. Canandaigua National Bank & Trust Co. now owns 2,340 shares of the financial services provider's stock worth $460,000 after acquiring an additional 130 shares in the last quarter. Finally, Central Valley Advisors LLC raised its stake in CME Group by 3.2% during the second quarter. Central Valley Advisors LLC now owns 6,679 shares of the financial services provider's stock worth $1,351,000 after acquiring an additional 205 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm's stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company's stock, valued at $2,877,504.39. This trade represents a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the firm's stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,028 shares of company stock worth $1,811,681. Insiders own 0.30% of the company's stock.

Analyst Ratings Changes

CME has been the subject of several recent analyst reports. Bank of America increased their price objective on CME Group from $177.00 to $180.00 and gave the stock an "underperform" rating in a research note on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $227.00 to $226.00 and set a "hold" rating on the stock in a report on Monday, November 11th. The Goldman Sachs Group increased their target price on CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a report on Thursday, October 3rd. Piper Sandler increased their target price on CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a report on Monday, October 28th. Finally, Oppenheimer increased their target price on CME Group from $245.00 to $258.00 and gave the stock an "outperform" rating in a report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus target price of $224.47.

Check Out Our Latest Research Report on CME Group

CME Group Trading Up 1.2 %

CME traded up $3.02 during midday trading on Thursday, reaching $246.02. 3,252,980 shares of the company were exchanged, compared to its average volume of 1,953,987. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $249.02. The stock has a market capitalization of $88.66 billion, a P/E ratio of 25.87, a PEG ratio of 5.55 and a beta of 0.56. The stock's 50-day simple moving average is $227.46 and its 200 day simple moving average is $212.77.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion for the quarter, compared to analysts' expectations of $1.59 billion. During the same quarter last year, the business earned $2.25 earnings per share. The company's revenue was up 18.4% compared to the same quarter last year. As a group, analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend is Monday, December 9th. CME Group's dividend payout ratio (DPR) is currently 48.37%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should you invest $1,000 in CME Group right now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 High Short Interest Stocks You Need to Watch

3 High Short Interest Stocks You Need to Watch

Learn how to navigate high short-interest stocks and identify the best entry points for your portfolio. Check out these 3 high short interest stocks to watch.

Recent Videos

How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains
5 REITs Poised for Growth in 2025 – Top Real Estate Investments to Watch
GameStop’s Cash Pile Grows: Will This Be Enough to Save the Company?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines